Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Curr Opin Immunol. 2011 Jun;23(3):407-13. doi: 10.1016/j.coi.2011.04.002. Epub 2011 Apr 21.

Next generation pneumococcal vaccines.

Author information

  • 1Division of Infectious Diseases, Children's Hospital, Harvard Medical School, Boston, MA, United States.

Abstract

Currently licensed pneumococcal vaccines are based on the generation of antibodies to the pneumococcal polysaccharide, of which there are more than 90 different types. While these vaccines are highly effective against the serotypes included, their high cost and limited serotype coverage limit their usefulness worldwide, particularly in low resource areas. Thus alternative or adjunctive options are being actively pursued. This review will present these various approaches, including variations of the polysaccharide-protein conjugate strategy, protein-based strategies, and whole cell pneumococcal vaccines. The immunological basis for these different approaches is discussed as well.

Copyright © 2011 Elsevier Ltd. All rights reserved.

PMID:
21514128
[PubMed - indexed for MEDLINE]
PMCID:
PMC3109250
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk